Patients | ||||||
---|---|---|---|---|---|---|
Pat. nr. | primary tumor site | age | sex | TNM stage | tumor volume V [cm3] | failure site |
1 | oropharynx | 60 | m | T4 N2b MO | 258.1 | T*/N† |
2 | oropharynx | 51 | m | T4 N2c MO | 126.2 | T* |
3 | larynx | 66 | m | T4 N2c MO | 153.7 | T*/N† |
4 | FOM‡ | 46 | m | T3 N2b MO | 59.0 | T* |
5 | BOT§ | 49 | m | T4 N2c MO | 287.6 | T*/N† |
6 | oropharynx | 48 | m | T2 N2c MO | 114.7 | T*/N† |
7 | FOM‡ | 68 | m | T4 Nl M0 | 213.7 | T*/N† |
8 | oropharynx | 65 | m | T3 N2c MO | 74.3 | - |
9 | hypopharynx/BOT§ | 51 | m | T4 N2c MO | 100.9 | - |
10 | oropharynx | 59 | m | T2 N3 MO | 172.4 | - |
11 | oropharynx | 50 | f | T4 N2c MO | 44.0 | - |
12 | larynx-/hypopharynx | 60 | m | T4 NO MO | 32.4 | - |
13 | oro-/hypopharynx | 49 | m | T3 N2c MO | 80.9 | - |
14 | oropharynx | 60 | f | T4 N2b MO | 52.4 | - |
15 | unknown | 68 | m | T4 Nl M0 | 125.5 | - |